Content about Growth hormones

March 25, 2013
SanMedica unveils new HGH-booster at Academy of Women's Health's Annual Congress

SanMedica International introduced its SeroVital-HGH, a new oral human-growth hormone booster formulated with women in mind, at the Academy of Women's Health's Annual Congress.

WASHINGTON —  SanMedica International on Friday introduced its SeroVital-HGH, a new oral human-growth hormone booster formulated with women in mind, at the Academy of Women's Health's Annual Congress here. 

December 27, 2012
Sierra Research Labs licenses distribution of SeroVital-hgh through GNC to Novex Biotech

Demand for SeroVital-hgh — a proprietary amino acid compound developed by Sierra Research Labs — has spiked in the past month. To help meet demand, the company on Dec. 21 announced distribution expansion through GNC.

NEW YORK — Demand for SeroVital-hgh — a proprietary amino acid compound developed by Sierra Research Labs — has spiked in the past month, in part due to recent exposure on news channels like CNN and on news programs like "The Today Show," the company announced last week. To help meet demand, the company on Dec. 21 announced distribution expansion through GNC. 

November 10, 2010
Egrifta receives regulatory approval

The Food and Drug Administration has approved a drug for treating excess fat development in...

SILVER SPRING, Md. The Food and Drug Administration has approved a drug for treating excess fat development in patients with HIV, the agency said Thursday.

 

The FDA approved Egrifta (tesamorelin) for treating HIV patients with lipodystrophy, a condition in which excess fat develops in different areas of the body, such as the abdominal organs. The condition is often a side effect of the retroviral drugs used to treat the disease.

 

 

August 26, 2010
FDA approves new use of first U.S.-approved follow-on biologic

The FDA approved Sandoz Omnitrope (somatropin [rDNA origin]) as a treatment for idiopathic short stature,...